Clinical Trial Update: Reducing Mortality in Adults With Advanced HIV Disease (REVIVE) [Phase 3]

View source ↗

Summary

Phase 3 trial REVIVE aims to reduce mortality in adults with advanced HIV disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Snippet

Sponsor: Population Health Research Institute | Conditions: HIV Disease Progression | Phase 3 | Status: RECRUITING